Transfer Factor Clarification

In reference to my previous letter published in The Scientist (Feb. 17, 1997, page 13), the implication in my text that polymerase chain reaction (PCR) results obtained by my colleagues Dimitri Viza and Giancarlo Pizza confirm mine was erroneous. My letter should have stated that Viza and Pizza also obtained promising results in AIDS. For instance, all nine AIDS patients treated with HIV-specific transfer factor (TF) who were anergic (negative) to the six common skin test antigens developed de

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In reference to my previous letter published in The Scientist (Feb. 17, 1997, page 13), the implication in my text that polymerase chain reaction (PCR) results obtained by my colleagues Dimitri Viza and Giancarlo Pizza confirm mine was erroneous.

My letter should have stated that Viza and Pizza also obtained promising results in AIDS. For instance, all nine AIDS patients treated with HIV-specific transfer factor (TF) who were anergic (negative) to the six common skin test antigens developed delayed cutaneous hypersensitivity reactions to these antigens (a surrogate marker for cell-mediated immunity) when tested at 60 days post-TF administration. They also reported stabilization of the condition in advanced AIDS patients for several years.

TF may not always have the same dramatic effect on PCR counts that I have seen so far in my AIDS patients. I feel strongly that our success is because we eradicate any excess toxic metals and correct ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies